Understanding Your CIMT Test Results: What the Numbers Mean

Your CIMT report is a clinician-reviewed picture of the inner two layers of your carotid artery wall. Thickness is not blockage. The measurement alone does not predict heart attack or stroke. A raw millimeter is not a home verdict, and there is no fixed internet cutoff for self-diagnosis. On CardioRisk-style reports we review at Renew, about 0.7 to 1.29 mm often marks pre-plaque thickening, and about 1.3 mm often marks plaque on that vendor pattern. Those figures are how we discuss your report, not DIY bands. We also read plaque type, plaque burden, and arterial age versus calendar age. If a vendor letter grade appears, ask which reference group was used. Do not self-grade. Your clinician should interpret the scan with age, blood pressure, lipids and ApoB context, smoking, diabetes, family history, plaque character, burden, and arterial age.

Your CIMT results are in. Let me walk you through how we actually read the report.

I've sat with thousands of patients who open a CardioRisk-style PDF and hunt for a single millimeter that will tell them they are safe. That is the wrong job for a raw IMT number. What helps is reading the artery wall, the plaque character, the burden, and the arterial age together, then deciding what to do next in clinic.

If you are still getting oriented to the test itself, start with what a CIMT scan is and CIMT testing explained, then come back here for how we review the report.

---

---

Your arteries are highways, and disease starts in the lining

Think of an artery as a highway. Blood is the traffic. The pavement is the wall.

The innermost surface is the endothelium. Healthy endothelium makes nitric oxide (NO), which helps the vessel relax, stay quiet, and keep the lining from getting sticky. When that lining is injured, the first structural change shows up in the intima, the thin inner layer CIMT is built to see, together with the media underneath it.¹

That is why we care about wall thickening before anyone has chest pain. The disease process starts in the lining, not in the open lane of the highway.

---

---

Soft plaque versus hard plaque

A CIMT report is not only a thickness number. On the images we also look at what kind of plaque is there, when plaque is present.

• Soft / hypoechoic plaque (often labeled H) looks darker on ultrasound. It is inflammation-rich. That is the plaque we worry can rupture and trigger a clot.
• Hard / echogenic plaque (often labeled E) looks brighter. It is more scarred and more dormant.

In clinic, a common goal is to stabilize soft plaque toward a harder, more dormant form (H moving toward E). That change in character can matter more than chasing a raw millimeter into a prettier band.

Plaque type is one reason a thinner-looking wall is not automatically "safer," and a thicker-looking wall is not automatically a blockage. Thickness is not blockage. See plaque in the carotid artery for how plaque presence sits next to wall thickness.

---

---

How we read a CardioRisk-style report at Renew

The reports we review most often follow a CardioRisk vendor pattern. The numbers below are how those reports are discussed with a clinician. They are not internet cutoffs for self-diagnosis, and they do not replace the rest of your history.

On that vendor pattern:

• About 1.3 mm often marks plaque
• About 0.7 to 1.29 mm often marks pre-plaque / wall thickening
• Plaque burden is the sum of plaque lesions, not a single site's millimeter
• Arterial age versus chronological age usually tells us more than a naked mm standing alone

Greater carotid IMT has been associated with higher cardiovascular event rates in population research. Lorenz and colleagues, in a 2007 Circulation meta-analysis, reported that each 0.10 mm difference in common-carotid IMT was associated with an age- and sex-adjusted relative risk of 1.15 for myocardial infarction and 1.18 for stroke.² That is a population-level association. It does not mean a measurement on your report predicts your personal heart attack or stroke.

If your report also prints a letter grade, treat it as a vendor comparison. Ask which reference group was used. Do not self-grade. Different databases compare you to different people.

The rest of the visit still matters: age, blood pressure, lipids and ApoB context, smoking, diabetes, family history, plaque character, burden, and arterial age. We read those together. For age- and sex-specific reading without a single cutoff chart, see CIMT normal range and CIMT test by age.

---

Why "I passed a stress test" can still leave you under-informed

A normal stress test is reassuring for flow today. It is a weak blanket for silent wall disease.

Stress tests often need roughly 70% flow-limiting stenosis before they flag a problem. Many events come from milder soft-plaque rupture, not from a tight, flow-limiting narrowing. In clinic we talk about this as high false reassurance: someone can pass a stress test and still have inflammation-rich plaque in the wall the day before an event.

CIMT looks at the wall and the plaque character, including disease that is not yet blocking the lane. That is the point of the test, and it is also why we refuse to turn one millimeter into a DIY verdict.

See CIMT versus a standard carotid ultrasound and CIMT versus a calcium score if you are sorting which test answers which question.

---

What actually drives the wall change

Cholesterol numbers are part of the picture. They are not the whole story.

The root pattern we teach is oxidative stress and inflammaging. The lining gets injured. ApoB particles get trapped in that lining. Chronic inflammation follows. That is how a highway wall goes from a quiet endothelium to thickened intima, then to soft plaque that can rupture.

Two people can carry similar cholesterol values and still have very different walls. That is why we image, and why we do not stop at a lipid panel.

---

Fire-alarm labs when soft plaque is present

When the images show soft / hypoechoic plaque, we often order vascular inflammation labs as part of the same clinical review:

• Lp-PLA2
• Myeloperoxidase (MPO)

These are clinician-ordered tests. They are not home kits, and this page will not give you reference ranges or a treatment algorithm to run on yourself. They help us ask whether the wall looks inflamed right now, alongside the images, your history, and the rest of your labs.

---

What we watch over time

One report is a snapshot. Repeat CIMT, when your clinician recommends it, helps us see whether wall thickening, plaque character, or burden is changing. That trajectory belongs in the same review as your blood pressure, ApoB context, and those fire-alarm labs, not in a self-graded band.

If you are asking about timing, see how often to get a CIMT test.

---

What's the bottom line on your CIMT results?

When you open the PDF, remember:

• Thickness is not blockage.
• The measurement alone does not predict heart attack or stroke.
• A clinician interprets the scan with age, blood pressure, lipids and ApoB context, smoking, diabetes, family history, plaque character, plaque burden, and arterial age.
• If a vendor letter grade appears, ask which reference group was used. Do not self-grade.

Your CIMT result is information before an event, when the wall can still be treated as a living tissue. Soft plaque can be watched for stabilization. Arterial age can be compared with the age on your driver's license. None of that is a promise of reversal, and none of it is a DIY report card.

The first useful step is a review that reads the whole report, not a millimeter you score at the kitchen table.

---

Ready to walk through what your results mean in clinic? View our CIMT scan options and pricing →

Or start with how a CIMT scan works and what to expect →

---

Related reading:

• CIMT Testing Explained
• CIMT Normal Range
• Plaque in Carotid Artery
• CIMT Test by Age
• CIMT Test vs. Carotid Ultrasound
• How Often Should You Get a CIMT Test?
• CIMT vs. Calcium Score
• CIMT Testing for Stroke Prevention

---

Sources

• Stein JH, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. J Am Soc Echocardiogr. 2008;21(2):93-111. PMID 18261694.
• Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115(4):459-467. PMID 17242284. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.106.628875

Footnotes

1. Stein JH, et al. "Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force." J Am Soc Echocardiogr. 2008;21(2):93-111. PMID: 18261694. ↩

2. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. "Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis." Circulation. 2007;115(4):459-467. PMID: 17242284. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.106.628875 ↩